Shah Hussain

Shah Hussain

Director/Board Member at MODERNA, INC.

Net worth: 554 312 $ as of 2026-04-29

61 year
Health Technology
Consumer Services
Finance

Profile

Shah Abbas Hussain occupies the position of Senior Partner at Shanghai Kangshiqiao Business Consulting Co. Ltd. He is also on the board of Teva Pharmaceutical Industries Ltd., Cochlear Ltd. and TargTex SA and President-Emerging Markets Asia Pacific at GlaxoSmithKline South Africa (Pty) Ltd. He previously occupied the position of Associate-Business Development at Eli Lilly & Co. President-Europe Operations at Eli Lilly & Co. Ltd. General Manager of Lilly Deutschland GmbH, General Manager for Lilly Pharma Holding GmbH, Managing Director at Lilly Ilaç Ticaret Ltd. Sti. Director-Sales & Marketing for Eli Lilly Ranbaxy Ltd. and Manager-District Sales at Eli Lilly Australia Pty Ltd. (which are all subsidiaries of Eli Lilly & Co.) and Global President-Pharmaceuticals & Vaccines at GlaxoSmithKline Plc and President-Emerging Markets & Asia Pacific at Genelabs Technologies, Inc. (a subsidiary of GlaxoSmithKline Plc). Shah Abbas Hussain received an undergraduate degree from Loughborough University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-05-05 12,066 ( 0% ) 554 312 $ 2026-04-29

Shah Hussain active positions

CompaniesPositionStart
MODERNA, INC. Director/Board Member 2024-10-01
Director/Board Member -
Chairman -
Corporate Officer/Principal 2009-11-30
Director/Board Member 2023-12-31

Former positions of Shah Hussain

CompaniesPositionEnd
Chief Executive Officer 2022-12-31
COCHLEAR LIMITED Director/Board Member 2021-07-19
TEVA PHARMACEUTICAL INDUSTRIES LIMITED Director/Board Member 2021-07-05
CSL LIMITED Director/Board Member 2021-06-24
░░░░░░░░░░ ░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Shah Hussain's experience

Training of Shah Hussain

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

73

1st degree connections

25

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies25

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Lilly Pharma Holding GmbH

Health Technology

Consumer Services

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Services